News Release
Safety Shot, Inc. (NASDAQ: SHOT): Upside Confirmed by Scientific Research
CGR-SHOT
As the wellness industry evolves, there is increasing interest in products that address specific consumer needs beyond traditional health solutions. One area with limited innovation has been managing the effects of alcohol consumption. Safety Shot, Inc. (Nasdaq: SHOT) is making strides in this space with its flagship drink. Safety Shot is a patented beverage designed to lower blood alcohol content (BAC) by accelerating alcohol metabolism. It also aims to enhance clarity, energy, and mood. Backed by recent scientific research and expanding its distribution network, Safety Shot is positioning itself as a key tool for responsible alcohol consumption. Scientific Backing of Safety Shot The foundation of Safety Shot’s market proposition is its scientific validation, supported by significant results from a clinical trial conducted by the Center for Applied Health Sciences (CAHS) and announced on August 12, 2024. This double-blind, randomized, placebo-controlled study demonstrated the product's effectiveness in reducing BAC. Participants aged 24 to 46, with varying body weights, showed a dramatic reduction in BAC, with some experiencing rates that dropped 30%–50% faster than the placebo group. Key findings included consistent reductions in both breath and blood alcohol content, enhanced energy levels, and improved concentration. Participants also reported less head discomfort and fatigue, further substantiating the product's claims. Chief Operations Officer and co-inventor David Sandler highlighted, “These results are revolutionizing the wellness space as we continue to pioneer the world’s most innovative functional beverages.” Dr. Tim Ziegenfuss, CEO of CAHS, echoed this sentiment: “These results are highly encouraging, showcasing Safety Shot’s potential as a beneficial supplement for individuals consuming alcohol.” Expansion Through Partnerships Safety Shot, Inc. has pursued expansion through strategic partnerships, significantly enhancing its market reach. In early June, the company announced their partnership with Mr. Checkout, a national network of independent distributors and grocery distributors. This collaboration aims to introduce Safety Shot to over 200,000 independent retail locations across the U.S., leveraging Mr. Checkout’s expertise in launching and scaling innovative products. Chief Revenue Officer Josh Wagner expressed optimism about the partnership: “This is a significant step forward in exploring new verticals of accessibility for our revolutionary product. We are confident that with Mr. Checkout’s support, we will be able to expand Safety Shot’s presence into diversified retailers to meet our customers where they prefer to shop.” Expanding in New York and New Jersey Furthering its expansion efforts, Safety Shot partnered with Prime CSB, a boutique broker with a strong presence in New York and New Jersey, to enhance its footprint in these key markets. Prime CSB’s personalized distribution approach is expected to help Safety Shot gain a solid foothold in these regions, particularly as demand surges during the peak summer season. Pharmacy Integration with Capital Drugs Safety Shot’s distribution efforts extend into the pharmacy sector through a deal with Capital Drugs, placing its product in 300 pharmacies nationwide. This partnership aligns Safety Shot with its wellness mission, allowing it to reach a like-minded consumer base that frequents pharmacies for health and wellness products. Northeast Presence via Atlantic Beverage Distributors To further bolster its market presence in the Northeast, Safety Shot partnered with Atlantic Beverage Distributors, a key player in Massachusetts and Rhode Island’s beverage markets. This collaboration is expected to significantly enhance Safety Shot’s presence in the region, thanks to Atlantic Beverage Distributors’ deep understanding of the market and extensive distribution network. Wagner noted, “Their expertise in the beverage and spirits industry and dedication to working with specialty products align perfectly with where we want to take Safety Shot as we continue to grow and expand.” Nationwide Reach with KeHE Distributors The company’s nationwide expansion strategy received a significant boost through a partnership with KeHE Distributors, a leading distributor of natural and organic products in North America. This alliance is expected to bring Safety Shot to thousands of new retail locations across the country, capitalizing on KeHE’s vast distribution network. Conclusion With robust scientific evidence and a series of strategic partnerships, Safety Shot, Inc. is poised to become a leader in the wellness and dietary supplement industries. As it continues to disrupt the market and redefine responsible alcohol consumption, investors may want to be closely watching its progress. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 Mark@razorpitch.com Company Website http://razorpitch.com
August 13, 2024 06:00 AM Eastern Daylight Time
News Release
